SCHEMBL27200375

SCHEMBL27200375

Cc1c(Cl)cccc1Nc1c(Cn2ccc3c(-c4cnn(C(CC#N)C5CCCC5)c4)ncnc32)cccc1C(=O)O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 10/20 0.46
JAK1 P23458 8/20 0.46
JAK3 P52333 4/20 0.46
TYK2 P29597 3/20 0.46
ABL1 P00519 3/20 0.46
DAPK3 O43293 2/20 0.46
PAK4 O96013 2/20 0.46
RET P07949 2/20 0.46
LTK P29376 2/20 0.46
CSNK1A1 P48729 2/20 0.46
CLK2 P49760 2/20 0.46
TNK2 Q07912 2/20 0.46
ROCK1 Q13464 2/20 0.46
DYRK1A Q13627 2/20 0.46
IKBKE Q14164 2/20 0.46
NTRK3 Q16288 2/20 0.46
NTRK2 Q16620 2/20 0.46
LRRK2 Q5S007 2/20 0.46
TAOK1 Q7L7X3 2/20 0.46
CAMK1D Q8IU85 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24902175 0.85 JAK1 (0.47) JAK2JAK1JAK3TYK2ABL1
SCHEMBL27200371 0.85 JAK1 (0.47) JAK2JAK1JAK3TYK2ABL1
SCHEMBL27246182 0.84 JAK2 (0.50) JAK2JAK1JAK3TYK2ABL1
SCHEMBL30722844 0.84 JAK2 (0.50) JAK2JAK1JAK3TYK2ABL1
SCHEMBL24902111 0.84 JAK2 (0.50) JAK2JAK1JAK3TYK2ABL1
SCHEMBL26610405 0.84 JAK1 (0.47) JAK2JAK1JAK3TYK2ABL1
SCHEMBL26610408 0.84 JAK1 (0.47) JAK2JAK1JAK3TYK2ABL1
SCHEMBL27246155 0.83 JAK2 (0.46) JAK2JAK1JAK3TYK2ABL1
SCHEMBL24902013 0.80 JAK2 (0.47) JAK2JAK1JAK3TYK2ABL1
SCHEMBL27200384 0.80 JAK2 (0.47) JAK2JAK1JAK3TYK2ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4357346-A1 EXTERNAL ANTI-INFLAMMATORY COUPLING COMPOUND DRUG, AND PREPARATION METHOD THEREFOR AND USE THEREOF Coval Biopharma (Shanghai) Co., Ltd. (CN) 2024-04-24 EP disclosed